BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 12935438)

  • 21. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of solid lipid nanoparticles in brain targeting.
    Kaur IP; Bhandari R; Bhandari S; Kakkar V
    J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructure-based drug delivery systems for brain targeting.
    Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
    Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling of the blood-brain barrier in drug discovery and development.
    Cecchelli R; Berezowski V; Lundquist S; Culot M; Renftel M; Dehouck MP; Fenart L
    Nat Rev Drug Discov; 2007 Aug; 6(8):650-61. PubMed ID: 17667956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M; McDannold N; Jolesz FA; Hynynen K
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1085-90. PubMed ID: 16403441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.
    Iqbal A; Ahmad I; Khalid MH; Nawaz MS; Gan SH; Kamal MA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):256-84. PubMed ID: 24024521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery to the brain using polymers.
    Domb A; Maniar M; Bogdansky S; Chasin M
    Crit Rev Ther Drug Carrier Syst; 1991; 8(1):1-17. PubMed ID: 1868550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cationization, a process for the delivery of antibodies to the central nervous system. Problems encountered in its application for immunotherapy strategies such as those for clostridial poisoning].
    Hervé F; Ouzilou-Girod J; Scherrmann JM
    J Soc Biol; 2001; 195(3):201-27. PubMed ID: 11833458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.